KIT and mastocytosis: HuMC‐derived EVs can transfer KIT to other cell types altering the recipient cell phenotypes and potentially contributing to the pathogenesis of mastocytosis (Kim et al., 2018; Kim et al., 2021; Xiao et al., 2014).